Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

NCT00866476 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Reactogenicity met study halting criteria

Conditions

Shigella

Interventions

BIOLOGICAL: CVD 1208S, a Shigella flexneri 2a live, oral vaccine
OTHER: Placebo

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]